U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07095998) titled 'Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy' on June 02.
Brief Summary: This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Peripheral Neuropathy Due to Chemotherapy
Peripheral Neuropathy
Neurotoxic...